Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

309 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Female hormones affect symptom severity in obsessive-compulsive disorder.
Vulink NC, Denys D, Bus L, Westenberg HG. Vulink NC, et al. Among authors: denys d. Int Clin Psychopharmacol. 2006 May;21(3):171-5. doi: 10.1097/01.yic.0000199454.62423.99. Int Clin Psychopharmacol. 2006. PMID: 16528139
[Inadequate pharmacotherapy in patients with obsessive-compulsive disorder].
Denys D, van Megen HJ, Westenberg HG. Denys D, et al. Ned Tijdschr Geneeskd. 2001 May 12;145(19):914-8. Ned Tijdschr Geneeskd. 2001. PMID: 11387867 Dutch.
The adequacy of pharmacotherapy in outpatients with obsessive-compulsive disorder.
Denys D, Van Megen H, Westenberg H. Denys D, et al. Int Clin Psychopharmacol. 2002 May;17(3):109-14. doi: 10.1097/00004850-200205000-00003. Int Clin Psychopharmacol. 2002. PMID: 11981351
Quetiapine addition to serotonin reuptake inhibitor treatment in patients with treatment-refractory obsessive-compulsive disorder: an open-label study.
Denys D, van Megen H, Westenberg H. Denys D, et al. J Clin Psychiatry. 2002 Aug;63(8):700-3. doi: 10.4088/jcp.v63n0807. J Clin Psychiatry. 2002. PMID: 12197450 Clinical Trial.
A case of venlafaxine-induced inhibition of T-lymphocyte proliferation.
Denys D, Kavelaars A, Heijnen CJ, Westenberg H. Denys D, et al. Psychopharmacology (Berl). 2002 Dec;164(4):432. doi: 10.1007/s00213-002-1249-1. Epub 2002 Oct 24. Psychopharmacology (Berl). 2002. PMID: 12457275 No abstract available.
Effect of a pharmacological intervention on quality of life in patients with obsessive-compulsive disorder.
Tenney NH, Denys DA, van Megen HJ, Glas G, Westenberg HG. Tenney NH, et al. Int Clin Psychopharmacol. 2003 Jan;18(1):29-33. doi: 10.1097/00004850-200301000-00005. Int Clin Psychopharmacol. 2003. PMID: 12490772 Clinical Trial.
Emerging skin-picking behaviour after serotonin reuptake inhibitor-treatment in patients with obsessive-compulsive disorder: possible mechanisms and implications for clinical care.
Denys D, van Megen HJ, Westenberg HG. Denys D, et al. J Psychopharmacol. 2003 Mar;17(1):127-9. doi: 10.1177/0269881103017001718. J Psychopharmacol. 2003. PMID: 12680750
A score for predicting response to pharmacotherapy in obsessive-compulsive disorder.
Denys D, Burger H, van Megen H, de Geus F, Westenberg H. Denys D, et al. Int Clin Psychopharmacol. 2003 Nov;18(6):315-22. doi: 10.1097/00004850-200311000-00002. Int Clin Psychopharmacol. 2003. PMID: 14571151 Clinical Trial.
A double blind comparison of venlafaxine and paroxetine in obsessive-compulsive disorder.
Denys D, van der Wee N, van Megen HJ, Westenberg HG. Denys D, et al. J Clin Psychopharmacol. 2003 Dec;23(6):568-75. doi: 10.1097/01.jcp.0000095342.32154.54. J Clin Psychopharmacol. 2003. PMID: 14624187 Clinical Trial.
[The inheritance of obsessive-compulsive disorders].
Denys DA, Cath DC. Denys DA, et al. Ned Tijdschr Geneeskd. 2003 Nov 1;147(44):2166-9. Ned Tijdschr Geneeskd. 2003. PMID: 14626833 Review. Dutch.
309 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback